Investigational Drug Information for Cathinone
✉ Email this page to a colleague
What is the drug development status for Cathinone?
Cathinone is an investigational drug.
There have been 3 clinical trials for Cathinone.
The most recent clinical trial was a Phase 1 trial, which was initiated on September 1st 2014.
The most common disease conditions in clinical trials are Amphetamine-Related Disorders, Substance-Related Disorders, and Disease. The leading clinical trial sponsors are Parc de Salut Mar, Instituto de Salud Carlos III, and Fundació Recerca Institut Germans Trias i Pujol.
Summary for Cathinone
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 448 |
| WIPO Patent Applications | 332 |
| Japanese Patent Applications | 45 |
| Clinical Trial Progress | Phase 1 (2014-09-01) |
| Vendors | 0 |
Recent Clinical Trials for Cathinone
| Title | Sponsor | Phase |
|---|---|---|
| Abuse Potential and Human Pharmacology of Methylone | Fundació Recerca Institut Germans Trias i Pujol | Phase 1 |
| Abuse Potential and Human Pharmacology of Methylone | Istituto Superiore di Sanità | Phase 1 |
| Abuse Potential and Human Pharmacology of Methylone | Germans Trias i Pujol Hospital | Phase 1 |
Clinical Trial Summary for Cathinone
Top disease conditions for Cathinone
Top clinical trial sponsors for Cathinone
US Patents for Cathinone
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
